Panitumumab binder til EGFR' s ligandbindende domæne og hæmmer receptor- autofosforylering, der induceres af alle kendte EGFR- ligander.
Panitumumab binds to the ligand binding domain of EGFR and inhibits receptor autophosphorylation induced by all known EGFR ligands.